StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)

Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –

Anbio Biotechnology r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $201.31K, down 55.7% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$201.31K-55.7%
FY2024Dec 31, 2024$454.23K+237.2%
FY2023Dec 31, 2023$134.70K-32.6%
FY2022Dec 31, 2022$200.00K–

More Anbio Biotechnology figures

See a number that looks wrong?